Sign up to save your podcasts
Or
Share 302: Vertex's big deal, biotech's red numbers, & an industry history lesson
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
302: Vertex's big deal, biotech's red numbers, & an industry history lesson
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.
View all episodes
By STAT
4.6
300300 ratings
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.
More shows like The Readout Loud
View all
WSJ Tech News Briefing
1,638 Listeners
WSJ What’s News
4,324 Listeners
The Daily
111,530 Listeners
KFF Health News' 'What the Health?'
468 Listeners
The Long Run with Luke Timmerman
117 Listeners
The Journal.
5,896 Listeners
Morning Brew Daily
2,933 Listeners
Tradeoffs
390 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
84 Listeners
BioCentury This Week
31 Listeners
Raising Health
141 Listeners
Biotech Hangout
9 Listeners
ACQ2 by Acquired
189 Listeners
Ground Truths
42 Listeners